- Home
- RXT vs FENC Comparison
RXT vs FENC Comparison
Compare RXT & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RXT | FENC |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.9M | 276.3M |
| IPO Year | 2020 | 2001 |
Fundamental Metrics
Financial Performance| Metric | RXT | FENC |
|---|---|---|
| Price | $0.76 | $7.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $1.61 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.1M | 173.0K |
| Earning Date | 02-19-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,688,500,000.00 | $38,790,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.63 | $70.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.79 | $4.68 |
| 52 Week High | $3.03 | $9.92 |
Technical Indicators
Market Signals| Indicator | RXT | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 26.49 | 50.95 |
| Support Level | $0.96 | $7.35 |
| Resistance Level | $1.05 | $7.84 |
| Average True Range (ATR) | 0.06 | 0.30 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 3.04 | 46.05 |
Price Performance
Historical ComparisonAbout RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.